A new generation of CAR T cell therapy is bringing hope in the fight against cancer, targeting not only blood cancers but also solid tumors such as ovarian and breast cancer. Fraunhofer researchers ...
Autologous CD19 CAR T products (tisagenlecleucel, axicabtagene ciloleucel, lisocabtagene maraleucel, brexucabtagene autoleucel) show high response rates across ALL and NHL, now including second-line ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results